Hint mode is switched on Switch off

Atreca, ordinary share
BCEL, US04965G1094

FIND, SAVE & TRACK INVESTMENTS WITH CBONDS WATCHLIST

With Cbonds Watchlist you can always stay updated on your investments to make conscious decisions!

Watchlist
You need to request access
Add a stock to WL
Choose all Reset all
Atreca, сountry — USA
No trading data
Data display in a chart | table
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
No data
from
to
ADD-IN
Cbonds add-in API
bond data api
Authorization required
You need to request access
More than 2,500 records have been found, please specify your request
No data for the selected period
Welcome to Cbonds
New to Cbonds? · Take a 90-second tour of the platform.

Discover what you can do with Cbonds

Everything you need for fixed income research and monitoring.

  • 00:23 Coverage
  • 00:40 Bond screener
  • 00:54 Parameters
  • 01:10 Watchlist, Mobile app
  • 01:15 Excel Add-in
Unlock data Watch full tour

Latest quotes

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Get access to the largest financial database

Representative of the company 7 days FREE trial

Professional access to the data

Private investor

Individual access

Issuer

Profile
Atreca, Inc. is a biopharmaceutical company, discovers and develops antibody-based immunotherapeutics to treat a range of solid tumor types. It was founded in 2010.
  • Issuer
  • Full borrower / issuer name
    Atreca Inc.
  • Industry
    Pharmaceutical Preparation and Biotechnology

Placement data

  • Placement type
    IPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    BCEL
  • Placement
    20.06.2019
  • Lock up period
    180
  • Number of papers
    7,350,000
  • Volume of raised funds
    124.95 mln USD
  • Placement share
    35.25%
  • Final placement price
    17 USD
  • Price change since placement date
    -100%
  • By capitalization
    354.45 mln USD
Other placements of the issuer
  • Placement type
    SPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    BCEL
  • Placement
    17.07.2020
  • Lock up period
    180
  • Number of papers
    7,812,500
  • Volume of raised funds
    125 mln USD
  • Placement share
    26.76%
  • Final placement price
    16 USD
  • Price change since placement date
    -100%
  • By capitalization
    467.05 mln USD

IFRS/US GAAP reports

2023
I q eng
II q eng
III q eng
2022
I q eng
II q eng
III q eng
IV q eng
2021
I q eng
II q eng
III q eng
IV q eng
2020
I q eng
II q eng
III q eng
IV q eng
2019
II q eng
III q eng
IV q eng
Show more Hide

Indicators

News

08/03/2024 Atreca: Notice Of Delisting Or Failure To Satisfy A Continued Listing Rule Or Standard; Transfer Of Listing
19/12/2023 Atreca: Entry Into A Material Definitive Agreement, Departure Of Directors Or Certain Officers; Election Of Directors; Appointment Of Certain Officers; Compensatory Arrangements Of Certain Officers, Regulation Fd Disclosure, Other Events, Financial Statements And Exhibits
14/11/2023 Atreca: Results Of Operations And Financial Condition, Financial Statements And Exhibits
15/09/2023 Atreca: Termination Of A Material Definitive Agreement, Departure Of Directors Or Certain Officers; Election Of Directors; Appointment Of Certain Officers; Compensatory Arrangements Of Certain Officers, Regulation Fd Disclosure, Financial Statements And Exhibits
08/09/2023 Atreca: Notice Of Delisting Or Failure To Satisfy A Continued Listing Rule Or Standard; Transfer Of Listing
All organization news

Holders

Industry Leaders

Registration is required to get access.